Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Alset EHome International | AEI | Nov 18, 2024 | 1.06 | +1.92 |
Alt5 Sigma | ALTS | Nov 18, 2024 | 2.33 | +10.43 |
Alta Equipment A Pref | ALTG-A | Nov 18, 2024 | 25.53 | -0.04 |
Alta Equipment Group A | ALTG | Nov 18, 2024 | 6.89 | -1.43 |
Alta Global Group | MMA | Nov 18, 2024 | 1.77 | -1.11 |
Altair Engineering A | ALTR | Nov 18, 2024 | 103.87 | +0.12 |
Altamira Therapeutics | CYTO | Nov 18, 2024 | 0.43 | -5.31 |
AltEnergy Acquisition A | AEAE | Nov 18, 2024 | 11.22 | 0.00 |
AltEnergy Acquisition Unit | AEAEU | Nov 18, 2024 | 11.30 | 0.00 |
Alterity Therapeutics ADR | ATHE | Nov 18, 2024 | 1.10 | -0.91 |
Alternus Clean Energy A | ALCE | Nov 18, 2024 | 1.58 | -9.71 |
Alti Global A | ALTI | Nov 18, 2024 | 4.30 | -2.05 |
Altice USA A | ATUS | Nov 18, 2024 | 2.37 | -4.05 |
Altimmune | ALT | Nov 18, 2024 | 7.15 | -6.04 |
Altisource Portfolio Solutions | ASPS | Nov 18, 2024 | 0.87 | +0.14 |
Alto Ingredients | ALTO | Nov 18, 2024 | 1.39 | +1.46 |
Alto Neuroscience | ANRO | Nov 18, 2024 | 4.60 | +1.77 |
Altria Group | MO | Nov 18, 2024 | 56.34 | +0.73 |
Altus Power A | AMPS | Nov 18, 2024 | 3.83 | -0.52 |
Alumis | ALMS | Nov 18, 2024 | 8.64 | -2.37 |
Alvotech | ALVO | Nov 18, 2024 | 12.10 | +3.15 |
ALX Oncology | ALXO | Nov 18, 2024 | 1.22 | -5.43 |
Alzamend Neuro | ALZN | Nov 18, 2024 | 1.35 | -0.74 |
Amalgamated Financial | AMAL | Nov 18, 2024 | 35.22 | -0.96 |
Amarin ADR | AMRN | Nov 18, 2024 | 0.47 | -7.00 |
Amazon.com | AMZN | Nov 18, 2024 | 201.70 | -0.45 |
Ambac Financial Group | AMBC | Nov 18, 2024 | 12.44 | +0.81 |
Ambarella | AMBA | Nov 18, 2024 | 57.44 | +0.91 |
Ambev ADR | ABEV | Nov 18, 2024 | 2.18 | -1.36 |
Ambipar Emergency Response | AMBI | Nov 18, 2024 | 5.30 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.